Perspective Therapeutics, Inc. (AMEX: CATX) last traded at $2.66, down 1.85% on the session. The quote above updates while this page is open; the figures below are drawn from Perspective Therapeutics, Inc.’s own filings and are restated only when a new one is published.
Perspective Therapeutics, Inc. trades on AMEX under the ticker CATX. Its market capitalisation is $303.64 million.
Valuation measures for Perspective Therapeutics, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $303.64M |
|---|---|
| Enterprise value | $323.32M |
| Price / book | 0.94 |
| Beta | 1.31 |
Trailing-twelve-month figures tagged in Perspective Therapeutics, Inc.'s XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$116.43M |
| EPS (TTM) | -$1.33 |
|---|
| Return on equity | -35.95% |
|---|
| Cash | $48.49M |
|---|
Range and volume for CATX over the past 52 weeks.
| 52-week high | $6.16 |
|---|---|
| 52-week low | $1.96 |
| Volume | 1.10M |
| Average volume | 1.66M |
| Previous close | $2.71 |
Invest a chosen dollar amount in Perspective Therapeutics, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CATX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.